First test of new drug to tame dangerous blood fats

This was an early-stage study to check the safety of an experimental drug called ALN-APOC3 in 32 adults with dyslipidemia, which means they have unhealthy levels of fats like cholesterol and triglycerides in their blood. The main goal was to see if the drug was safe and how the body processed it, while also measuring if it changed blood fat levels. This type of first-in-human study is a crucial first step to see if a new treatment is worth developing further.